Back

Ulnar Nerve Entrapment

Also known as: Cubital Tunnel Syndrome, Ulnar Neuropathy

Ulnar neuropathy at the elbow (cubital tunnel syndrome) is the second most common upper limb compressive neuropathy after carpal tunnel syndrome. Incidence is roughly 20 to 25 per 100,000 per year, with a male predominance. Compression at the wrist (Guyon canal) is much less common.

Anatomy of the nerve (C8 to T1, medial cord)

  • It runs in the medial arm, passes behind the medial epicondyle in the ulnar groove, and enters the cubital tunnel between the two heads of flexor carpi ulnaris, beneath the Osborne ligament.
  • It supplies flexor carpi ulnaris and the ulnar half of flexor digitorum profundus, then the hypothenar muscles, interossei, ulnar two lumbricals, adductor pollicis and deep flexor pollicis brevis.
  • The dorsal ulnar cutaneous branch leaves about 5 to 8 cm proximal to the wrist, and the palmar cutaneous branch leaves in the forearm. Both are spared in Guyon canal lesions.

Sites of compression at the elbow

  • Arcade of Struthers (about 8 cm proximal to the medial epicondyle) and medial intermuscular septum.
  • The retrocondylar groove.
  • The cubital tunnel and Osborne ligament.
  • The deep flexor pronator aponeurosis.

Contributing factors

  • Prolonged elbow flexion (phone use, sleeping with elbows flexed), leaning on the elbow, and repetitive flexion.
  • Nerve subluxation or snapping over the epicondyle (10 to 16% of the population have a hypermobile nerve).
  • Osteophytes and osteoarthritis, previous elbow fractures and valgus deformity (tardy ulnar palsy), anconeus epitrochlearis, ganglion, lipoma, and synovitis.
  • Diabetes, alcohol, hypothyroidism, haemodialysis, and body habitus.

Guyon canal causes include cycling (handlebar palsy), hamate hook fracture, ganglion, ulnar artery thrombosis or aneurysm (hypothenar hammer syndrome), pisiform fracture, and repetitive hand use.

Pathophysiology: elbow flexion stretches the nerve by about 5 mm and narrows the tunnel, raising intraneural pressure by several fold, which impairs microcirculation. The McGowan grading is mild (I: sensory only), moderate (II: weakness) and severe (III: paralysis and atrophy).

Related

Clinical toolsCalculators

Latest content

Atlas’ Videos

On the evidence

Doses are traceable.

Management sections cite the guideline they came from. Atlas supports clinical judgement rather than replacing it; verify against current national guidance and the patient in front of you.

Learn it.
Know it.
Own it.